Available Prescription Medications Three distinct prescription medications are currently available, all manufactured by Novo Nordisk
It is essential to regularly check expiration dates and consult with healthcare professionals if you have any concerns about the quality or effectiveness of your medication
FDA Approves Oral Semaglutide as the First GLP-1 Pill for Weight Loss The FDAs approval of oral semaglutide marks a major step forward in obesity medicine, bringing the proven weight loss benefits of GLP-1 therapy to a convenient daily tablet
Some patients experience abdominal pain (common) or abdominal distension (common), which may present as cramping or a persistent ache in the upper abdomensymptoms that overlap considerably with dyspepsia
Because of the unknown potential for serious adverse reactions in the breastfed infant due to the possible accumulation of SNAC, an absorption enhancer for Wegovy tablets, and because there are alternative formulations of semaglutide that do not contain SNAC that can be used during lactation, advise patients that breastfeeding is not recommended during treatment with Wegovy tablets